A clinical study to evaluate the efficacy of Ashwagandhadi vati and Muktashuktadi vati in the treatment of Osteoporosis (Asthi kshaya)

A study of osteoporosis w.s.r to asthi kshaya and its management by ashwagandhadi vati and mukta-shuktibhasmadi vati

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/06/007052

Enrollment

Registered

2016-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Osteoporosis

Interventions

Intervention1: Ashwagandhadi vati: orally 1 tab(500mg) after meal twice a day with water for 8weeks follow up 4 weeks Intervention2: Mukta-shuktibhasmadi vati: orally 1 tab (500mg) before meall twice

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Osteoporosis diagnosed by Bone Mineral Density test. Patients willing to participate in the clinical trial. Patients complaining of symptoms; joint pain, backache pain in the bones, which will be confirmed later by the BMD-test.

Exclusion criteria

Exclusion criteria: Patients below 40 years of age Patients above 70 years of age Pregnant women and lactating women. Patients associated with other systemic disorders. Hyperparathyroidism Patients who have undergone chemotherapy and radiotherapy

Design outcomes

Primary

Measure	Time frame
Change in the clinical symptoms of Osteoporosis like Backache, Joint pain, Pain in the bones Timepoint: 8weeks and 4 weeks follow up	—

Secondary

Measure	Time frame
Change in the Bone mineral density testTimepoint: 8weeks and 4 weeks follow up	—

Countries

India

Contacts

Public ContactDr Alankruta Dave

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026